Prime Therapeutics held drug spending to just 2.5 percent in 2016, saving clients more than $2.2 billion
Prime’s low drug trend is an indication of how effective its efforts were over the past year to manage costs and make medicines more affordable.
News from Prime
Four of six Minnesota locations to move, field sites in other states not affected.
Prime responds strongly by excluding Auvi-Q from its formulary or requiring the use of a lower cost epinephrine, similar to the recent actions of other PBMs.
Prime’s Omaha and Albuquerque teams again receive Service Quality Measurement Group’s (SQM) World Class Certification for delivering a superior member experience and industry leading service.
Prime in the news
Billings Gazette | January 16, 2017
Motley Fool | January 8, 2017
Motley Fool | January 7, 2017
Chain Drug Review | December 12, 2016